PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 126 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $1,000 | -98.8% | 252 | -99.1% | 0.00% | – |
Q1 2022 | $82,000 | -4.7% | 28,399 | 0.0% | 0.00% | – |
Q4 2021 | $86,000 | -35.3% | 28,399 | +49.1% | 0.00% | – |
Q3 2021 | $133,000 | -23.6% | 19,041 | +0.4% | 0.00% | – |
Q2 2021 | $174,000 | -15.1% | 18,959 | -10.0% | 0.00% | – |
Q1 2021 | $205,000 | -28.3% | 21,074 | -24.5% | 0.00% | – |
Q4 2020 | $286,000 | +1.4% | 27,900 | 0.0% | 0.00% | – |
Q3 2020 | $282,000 | -3.1% | 27,900 | 0.0% | 0.00% | – |
Q2 2020 | $291,000 | +23.8% | 27,900 | 0.0% | 0.00% | – |
Q1 2020 | $235,000 | +55.6% | 27,900 | +62.2% | 0.00% | – |
Q4 2019 | $151,000 | -52.8% | 17,200 | -42.1% | 0.00% | – |
Q3 2019 | $320,000 | -15.1% | 29,700 | 0.0% | 0.00% | – |
Q2 2019 | $377,000 | -67.3% | 29,700 | 0.0% | 0.00% | -100.0% |
Q1 2019 | $1,152,000 | +90.7% | 29,700 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $604,000 | -76.1% | 29,700 | -46.1% | 0.00% | -66.7% |
Q3 2018 | $2,526,000 | -16.2% | 55,092 | +8.2% | 0.00% | -25.0% |
Q2 2018 | $3,013,000 | +8.5% | 50,932 | +24.8% | 0.00% | +33.3% |
Q1 2018 | $2,776,000 | -33.5% | 40,798 | -3.4% | 0.00% | -40.0% |
Q4 2017 | $4,175,000 | -22.2% | 42,237 | -5.7% | 0.01% | -28.6% |
Q3 2017 | $5,364,000 | +90.3% | 44,792 | +38.9% | 0.01% | +75.0% |
Q2 2017 | $2,818,000 | +145.9% | 32,247 | +4.7% | 0.00% | +100.0% |
Q1 2017 | $1,146,000 | +40.3% | 30,801 | +15.8% | 0.00% | +100.0% |
Q4 2016 | $817,000 | -54.2% | 26,600 | 0.0% | 0.00% | -66.7% |
Q3 2016 | $1,784,000 | +4.5% | 26,600 | -53.6% | 0.00% | +50.0% |
Q2 2016 | $1,707,000 | +1.4% | 57,300 | 0.0% | 0.00% | -33.3% |
Q1 2016 | $1,683,000 | -62.5% | 57,300 | 0.0% | 0.00% | -57.1% |
Q4 2015 | $4,492,000 | +4.0% | 57,300 | 0.0% | 0.01% | 0.0% |
Q3 2015 | $4,318,000 | -27.5% | 57,300 | +12.4% | 0.01% | -22.2% |
Q2 2015 | $5,952,000 | +2216.0% | 50,982 | +4585.8% | 0.01% | – |
Q1 2015 | $257,000 | -45.8% | 1,088 | -45.2% | 0.00% | -100.0% |
Q3 2014 | $474,000 | – | 1,985 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 1,417,000 | $18,010,000 | 2.24% |
Palo Alto Investors LP | 1,405,680 | $17,866,000 | 0.87% |
PFM Health Sciences, LP | 2,838,376 | $36,076,000 | 0.68% |
TANG CAPITAL MANAGEMENT LLC | 349,400 | $4,441,000 | 0.60% |
Capital Impact Advisors, LLC | 127,029 | $1,615,000 | 0.59% |
Leap Investments LP | 29,100 | $370,000 | 0.50% |
Spark Investment Management LLC | 454,300 | $5,774,000 | 0.40% |
Partner Investment Management, L.P. | 27,567 | $350,000 | 0.37% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 262,945 | $3,342,000 | 0.26% |
Rock Springs Capital Management LP | 534,400 | $6,792,000 | 0.25% |